Blood pressure-lowering effect of melatonin in type 1 diabetes

Journal of Pineal Research

Volumn 36, Issue 4, 2004, Pages 262-266

  Cavallo, Anita ^a,b   Daniels, Stephen R ^a   Dolan, Lawrence M ^a   Bean, Judy A ^a   Khoury, Jane C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; MELATONIN;

ACTIMETRY; ADOLESCENT; ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PILOT STUDY; SLEEP; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERTENSION; MALE; MELATONIN; SLEEP;

EID: 1942435941     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00126.x     Document Type: Article

References (22)

1. EPSTEIN M, SOWERS JR. Diabetes mellitus and hypertension. Hypertension 1992; 19:403-418.
2. LURBE A, REDON J, PASCUAL JM, TACONS J, ALVAREZ V, BATLLE DC. Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 1993; 21:227-235.
3. ARANGINO S, CAGNACCI A, ANGIOLUCCI M et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999; 83:1417-1419.
4. LUSARDI P, PRETI P, SAVINO S, PIAZZA E, ZOPPI A, FOGARI R. Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Pressure Monitor 1997; 2:99-103.
5. CAGNACCI A, ARANGINO S, ANGIOLUCCI M, MASCHIO E, MELIS GB. Influences of melatonin administration on the circulation of women. Am J Physiol 1998; 274 (2 Pt 2):R335-R338.
6. CAVALLO A, DANIELS SR, DOLAN LM, KHOURRY JC, BEAN J. Blood pressure response to melatonin in type 1 diabetes. Ped Diabetes 2004; in press.
7. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program [see comments]. Pediatrics 1996; 98:649-658.
8. HARSHFIELD G, HWANG C, BLANK C, PICKERING T. Research techniques for ambulatory blood pressure monitoring. In: Handbook of Research Methods in Cardiovascular Behavioral Medicine. SCHNEIDERMAN N, WEISS S, KAUFMANN P eds, Plenum, New York, 1989; pp. 293-310.
9. SADEH A, SHARKEY KM, CARSKADON MA. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep 1994; 17:201-207.
10. COLE RJ, KRIPKE DF, GRUEN W, MULLANEY DJ, GILLIN JC. Automatic sleep/wake identification from wrist activity. Sleep 1992; 15:461-469.
11. MANSOOR G, WHITE W. Ambulatory blood pressure and cardiovascular risk stratification. J Vasc Med Biol 1994; 5:61-68.
12. LURBE E, REDON J, KESANI A et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797-805.
13. TERZOLO M, PIOVESAN A, PULIGHEDDU B et al. Effects of long-term, low-dose, time-specified melatonin administration on endocrine and cardiovascular variables in adult men. J Pineal Res 1990; 9:113-124.
14. VAN DE LUIT L, VAN DER MEULEN J, CLEOPHAS TJ, ZWINDERMAN AH. Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology 1998; 49:903-908.
15. VAN DONGEN HP, MAISLIN G, KERKHOF GA. Repeated assessment of the endogenous 24-hour profile of blood pressure under constant routine. Chronobiol Int 2001; 18:85-98.
16. ZHDANOVA IV, WURTMAN RJ, LYNCH HJ et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57:552-558.
17. GARFINKEL D, LAUDON M, NOF D, ZISAPEL N. Improvement of sleep quality in elderly people by controlled-release melatonin [see comments]. Lancet 1995; 346:541-544.
18. BRZEZINSKI A. Melatonin in humans. N Engl J Med 1997; 336:186-195.
19. ARENDT J. Safety of melatonin in long-term use (?). J Biol Rhythms 1997; 12:673-681.
20. SACK RL, LEWY AJ, HUGHES RJ. Use of melatonin for sleep and circadian rhythm disorders. Ann Med 1998; 30:115-121.
21. CARELLA MJ, GOSSAIN VV, ROVNER DR. Early diabetic nephropathy. Emerging treatment options. Arch Intern Med 1994; 154:625-660.
22. CHIARELLI F, CASANI A, VERROTTI A, MORGESE G, PINELLI L. Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors. Acta Paediatr Suppl 1998; 425:42-45.